These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 32122355)

  • 1. Role of non-coding RNAs and RNA modifiers in cancer therapy resistance.
    Zhang X; Xie K; Zhou H; Wu Y; Li C; Liu Y; Liu Z; Xu Q; Liu S; Xiao D; Tao Y
    Mol Cancer; 2020 Mar; 19(1):47. PubMed ID: 32122355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNAs regulate drug resistance in cancer.
    Liu K; Gao L; Ma X; Huang JJ; Chen J; Zeng L; Ashby CR; Zou C; Chen ZS
    Mol Cancer; 2020 Mar; 19(1):54. PubMed ID: 32164712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
    Fanale D; Castiglia M; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():207-28. PubMed ID: 27573902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
    Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
    Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of non-coding RNAs mediated pyroptosis on cancer therapy: a review.
    Zhao D; Wu T; Tan Z; Xu J; Lu Z
    Expert Rev Anticancer Ther; 2024 May; 24(5):239-251. PubMed ID: 38594965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
    Chen C; Tang X; Liu Y; Zhu J; Liu J
    Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer.
    Jin KT; Lu ZB; Lv JQ; Zhang JG
    RNA Biol; 2020 Dec; 17(12):1727-1740. PubMed ID: 32129701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncoding RNAs in gastric cancer: implications for drug resistance.
    Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
    Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncoding RNAs in Therapeutic Resistance of Cancer.
    Jia L; Yang A
    Adv Exp Med Biol; 2016; 927():265-95. PubMed ID: 27376739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-coding RNA in drug resistance of hepatocellular carcinoma.
    Ding B; Lou W; Xu L; Fan W
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNAs; potential contributors in cancer chemoresistance through modulating diverse molecular mechanisms and signaling pathways.
    Alsaab HO; Alzahrani MS; F Alaqile A; Waggas DS; Almutairy B
    Pathol Res Pract; 2024 Aug; 260():155455. PubMed ID: 39043005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNAs in anti-cancer drug resistance.
    Chen QN; Wei CC; Wang ZX; Sun M
    Oncotarget; 2017 Jan; 8(1):1925-1936. PubMed ID: 27713133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncoding RNAs in cancer therapy resistance and targeted drug development.
    Wang WT; Han C; Sun YM; Chen TQ; Chen YQ
    J Hematol Oncol; 2019 Jun; 12(1):55. PubMed ID: 31174564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
    Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
    Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol: Targeting Cancer Stem Cells and ncRNAs to Overcome Cancer Drug Resistance.
    Rezakhani L; Salmani S; Eliyasi Dashtaki M; Ghasemi S
    Curr Mol Med; 2024; 24(8):951-961. PubMed ID: 37592772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of long non-coding RNA H19 in therapy resistance of digestive system cancers.
    Wang J; Ma X; Si H; Ma Z; Ma Y; Wang J; Cao B
    Mol Med; 2021 Jan; 27(1):1. PubMed ID: 33402118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of non-coding RNAs in gastric cancer.
    Yang Q; Zhang RW; Sui PC; He HT; Ding L
    World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNAs Roles in Chemoresistance of Cancer Cells.
    Taghvimi S; Abbaszadeh S; Banan FB; Fard ES; Jamali Z; Najafabadi MA; Savardashtaki A; Movahedpour A
    Curr Mol Med; 2022; 22(8):691-702. PubMed ID: 34711162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer.
    Malek E; Jagannathan S; Driscoll JJ
    Oncotarget; 2014 Sep; 5(18):8027-38. PubMed ID: 25275300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
    Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
    Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.